HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesisTingdong Yan, Shang Li, Lai-Fong Poon et al.|Nature Communications|2018Cited by 52
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*Jennifer Tom, Fang Cai, Min Bao et al.|Critical Care Medicine|2021Cited by 42
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Patrick Tan, Wen Fong Ooi et al.|Journal of Clinical Investigation|2020Cited by 33
Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trialJennifer Tom, Fang Cai, Min Bao et al.|medRxiv|2020Cited by 5